These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35452631)

  • 21. CXCL13 drives spinal astrocyte activation and neuropathic pain via CXCR5.
    Jiang BC; Cao DL; Zhang X; Zhang ZJ; He LN; Li CH; Zhang WW; Wu XB; Berta T; Ji RR; Gao YJ
    J Clin Invest; 2016 Feb; 126(2):745-61. PubMed ID: 26752644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoimmunity to uroplakin II causes cystitis in mice: a novel model of interstitial cystitis.
    Altuntas CZ; Daneshgari F; Sakalar C; Goksoy E; Gulen MF; Kavran M; Qin J; Li X; Tuohy VK
    Eur Urol; 2012 Jan; 61(1):193-200. PubMed ID: 21719190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemokine CXCL13 activates p38 MAPK in the trigeminal ganglion after infraorbital nerve injury.
    Zhang Q; Zhu MD; Cao DL; Bai XQ; Gao YJ; Wu XB
    Inflammation; 2017 Jun; 40(3):762-769. PubMed ID: 28155010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CXCL13-CXCR5 axis promotes the growth and invasion of colon cancer cells via PI3K/AKT pathway.
    Zhu Z; Zhang X; Guo H; Fu L; Pan G; Sun Y
    Mol Cell Biochem; 2015 Feb; 400(1-2):287-95. PubMed ID: 25476740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elucidation of the pathophysiology of interstitial cystitis/bladder pain syndrome via experimental autoimmune cystitis rat model.
    Kadekawa K; Nishijima S; Noguchi K; Matsumoto S; Sugaya K
    Am J Physiol Regul Integr Comp Physiol; 2024 Aug; 327(2):R250-R260. PubMed ID: 38842512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The CXCL13/CXCR5-chemokine axis in neuroinflammation: evidence of CXCR5+CD4 T cell recruitment to CSF.
    Harrer C; Otto F; Pilz G; Haschke-Becher E; Trinka E; Hitzl W; Wipfler P; Harrer A
    Fluids Barriers CNS; 2021 Aug; 18(1):40. PubMed ID: 34446066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CXCL13/CXCR5 signaling axis in cancer.
    Hussain M; Adah D; Tariq M; Lu Y; Zhang J; Liu J
    Life Sci; 2019 Jun; 227():175-186. PubMed ID: 31026453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CXCL13/CXCR5 signaling enhances BCR-triggered B-cell activation by shaping cell dynamics.
    Sáez de Guinoa J; Barrio L; Mellado M; Carrasco YR
    Blood; 2011 Aug; 118(6):1560-9. PubMed ID: 21659539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered Expression of CXCL13 and CXCR5 in Intractable Temporal Lobe Epilepsy Patients and Pilocarpine-Induced Epileptic Rats.
    Li R; Ma L; Huang H; Ou S; Yuan J; Xu T; Yu X; Liu X; Yang J; Chen Y; Peng X
    Neurochem Res; 2017 Feb; 42(2):526-540. PubMed ID: 27873133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ETV4 promotes pancreatic ductal adenocarcinoma metastasis through activation of the CXCL13/CXCR5 signaling axis.
    Gao X; Jiang M; Chu Y; Han Y; Jin Y; Zhang W; Wang W; Yang S; Li W; Fan A; Cao J; Wang J; Liu H; Fu X; Chen D; Nie Y; Fan D
    Cancer Lett; 2022 Jan; 524():42-56. PubMed ID: 34582976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of key pathways and mRNAs in interstitial cystitis/bladder pain syndrome treatment with quercetin through bioinformatics analysis of mRNA-sequence data.
    Wang G; Li P; Su SW; Xu R; Huang ZY; Yang TX; Li JM
    Aging (Albany NY); 2024 Mar; 16(7):5949-5966. PubMed ID: 38526326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activated platelets promote increased monocyte expression of CXCR5 through prostaglandin E2-related mechanisms and enhance the anti-inflammatory effects of CXCL13.
    Halvorsen B; Smedbakken LM; Michelsen AE; Skjelland M; Bjerkeli V; Sagen EL; Taskén K; Bendz B; Gullestad L; Holm S; Biessen EA; Aukrust P
    Atherosclerosis; 2014 Jun; 234(2):352-9. PubMed ID: 24732574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-9-enriched mesenchymal stem cells derived exosomes prevent cystitis-induced bladder pain via suppressing TLR4/NLRP3 pathway in interstitial cystitis mice.
    Cui X; Bi X; Zhang X; Zhang Z; Yan Q; Wang Y; Huang X; Wu X; Jing X; Wang H
    Immun Inflamm Dis; 2024 Feb; 12(2):e1140. PubMed ID: 38415918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for the Role of Mast Cells in Cystitis-Associated Lower Urinary Tract Dysfunction: A Multidisciplinary Approach to the Study of Chronic Pelvic Pain Research Network Animal Model Study.
    Wang X; Liu W; O'Donnell M; Lutgendorf S; Bradley C; Schrepf A; Liu L; Kreder K; Luo Y
    PLoS One; 2016; 11(12):e0168772. PubMed ID: 28002455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can the adrenergic system be implicated in the pathophysiology of bladder pain syndrome/interstitial cystitis? A clinical and experimental study.
    Charrua A; Pinto R; Taylor A; Canelas A; Ribeiro-da-Silva A; Cruz CD; Birder LA; Cruz F
    Neurourol Urodyn; 2015 Jun; 34(5):489-96. PubMed ID: 24375689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Temporally complex inflammatory networks in an animal model reveal signatures for interstitial cystitis and bladder pain syndrome phenotype.
    Shah AM; Vodovotz Y; Yoshimura N; Chermansky CJ; Fitzgerald J; Tyagi P
    Neurourol Urodyn; 2023 Nov; 42(8):1839-1848. PubMed ID: 37587846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein Kinase C Epsilon Cooperates with PTEN Loss for Prostate Tumorigenesis through the CXCL13-CXCR5 Pathway.
    Garg R; Blando JM; Perez CJ; Abba MC; Benavides F; Kazanietz MG
    Cell Rep; 2017 Apr; 19(2):375-388. PubMed ID: 28402859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypermethylation of Single CpG Dinucleotides at the Promoter of CXCL13 Gene Promoting Cell Migration in Cervical Cancer.
    Ma D; Fan SB; Hua N; Li GH; Chang Q; Liu X
    Curr Cancer Drug Targets; 2020; 20(5):355-363. PubMed ID: 31899677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered expression of the receptor-ligand pair CXCR5/CXCL13 in B cells during chronic HIV-1 infection.
    Cagigi A; Mowafi F; Phuong Dang LV; Tenner-Racz K; Atlas A; Grutzmeier S; Racz P; Chiodi F; Nilsson A
    Blood; 2008 Dec; 112(12):4401-10. PubMed ID: 18780835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased CXCL13 and CXCR5 in Anterior Cingulate Cortex Contributes to Neuropathic Pain-Related Conditioned Place Aversion.
    Wu XB; He LN; Jiang BC; Wang X; Lu Y; Gao YJ
    Neurosci Bull; 2019 Aug; 35(4):613-623. PubMed ID: 31041693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.